Skip to content
  • Home
    • Journal information
    • Editorial board
    • Operations manual
    • Editorial policies
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • TOC Alert
    • Current issue
  • Information
    • Editorial & Peer Review
    • Ethical policies
    • Funding
    • Complaints and appeals
    • Open access and licensing
    • Authors
    • Sponsorship
    • Contact
  • Publish
    • Instructions to authors
    • Online submission
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • Home
    • Journal Information
    • Editorial Board
    • Operations Manual
    • Editorial Polices
    • Code of conduct for authors
    • Code of conduct for reviewers
  • Ahead of print
  • Read
    • Archive
    • Toc Alert
    • Current issue
  • Information
    • Editorial & Peer review
    • Ethical policies
    • Funding
    • Procedure for complaints and/or appeals
    • Open access & Licensing
    • Authors
    • Sponsors
    • Contact
  • Publish
    • Authors Instructions
    • Online submission
  • ES
  • EN
0,00 € 0 Cart
  • TOC Alert

Author: creacionmx

Origin and Diversity of Human Retroviruses

HIV-2 and HTLV-1 Infections in Spain, a Non-Endemic Region

HIV/Dendritic Cell Interaction: Consequences in the Pathogenesis of HIV Infection

Genetic Barrier to Resistance for Dolutegravir

Catch Me If You Can – The Race Between HIV and Neutralizing Antibodies

Is It Time for Integrase Inhibitors to be the Preferred Regimen for the First-Line Treatment of HIV-1-Infected Naive Patients?

HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions

The Human Immune Response to HIV and its Impact in the Potential Development of an Inactivated HIV Vaccine

Body Fat Changes in People Living with HIV on Antiretroviral Therapy

Non-Alcoholic Fatty Liver Disease in HIV Infection

← previous
Next →
PERMANYER
  • permanyer@permanyer.com
  • www.permanyer.com

Mallorca, 310
08037 Barcelona (España)

Arquímedes, 190 – Colonia Polanco
Delegación Miguel Hidalgo
11560 Ciudad de México (México)

RECURRING LINKS
  • Current Issue
  • Ahead of Print
  • Archive
  • Online submission
  • Contact
CLOCKSS is a dak archive that ensures the long-term survival of web-based scholary publications, governed by and for its stakeholders.

This journal adheres to the principles established by the Committee on Publication Ethics

Visitors: 44,559

  • Copyright 2025
  • Legal Notice
  • Permissions & Reprints
  • Data Protection Policy
  • Ethics Code
  • Conflicts of Interest